Low Dose Aspirin Studied With the AggreGuide
NCT01603966 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 13
Last updated 2012-07-17
Summary
This study is to determine whether the AggreGuide platelet aggregometer can discern the effect of low dose aspirin on subjects platelet aggregation using arachidonic acid as the agonist.
Conditions
- Platelet Aggregation
Sponsors & Collaborators
-
Edward R. Teitel, M.D.
lead INDUSTRY
Principal Investigators
-
Edward R. Teitel, MD · Aggredyne, Inc.
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2012-04-30
- Primary Completion
- 2012-06-30
- Completion
- 2012-06-30
Countries
- United States
Study Locations
More Related Trials
-
Whole Blood Platelet Aggregation in Chronic Kidney Disease Patients on Aspirin Study
NCT01768637 ·Status: COMPLETED ·Phase: PHASE1
-
Aspirin in Patients With Myocardial Infarction and Thrombocytopenia
NCT00501345 ·Status: TERMINATED ·Phase: PHASE3
-
Mechanism of Dipyridamole Action in Platelets: in Vivo Study With Healthy Volunteers
NCT02226926 ·Status: COMPLETED ·Phase: PHASE1
-
Dose-related Effect of Aspirin on Laboratory-defined Acetylsalicylic Acid Resistance and Clinical Outcome After Coronary Stenting
NCT00966485 ·Status: COMPLETED ·Phase: NA
-
The Effect of Serum LDL Lowering on Aspirin Resistance
NCT00466154 ·Status: COMPLETED ·Phase: NA
-
Study to See if Platelet Transfusion Stop or Lessen the Effect of the Drug on Platelets
NCT01744288 ·Status: COMPLETED ·Phase: PHASE1
-
Naproxen Sodium/ASA Platelet Study
NCT02229461 ·Status: COMPLETED ·Phase: PHASE1
-
Platelet Drug Trial in Coronary Disease Progression
NCT00000496 ·Status: COMPLETED ·Phase: PHASE3
-
Duration of Platelet Inhibition by Aspirin
NCT00671021 ·Status: COMPLETED
-
Platelet Hyperreactivity to Aspirin and Stroke
NCT00766896 ·Status: COMPLETED ·Phase: PHASE4
-
Serum Thromboxane B2 Assay as a Measure of Platelet Production in Healthy Volunteers Taking Aspirin
NCT03424408 ·Status: COMPLETED ·Phase: NA
-
Arachidonic Acid-induced Platelet Aggregation Rate in Patients With Stable CAD Treated With Ticagrelor Monotherapy
NCT02219412 ·Status: COMPLETED ·Phase: PHASE4
-
COMT on Aspirin Platelets Effects (CAPE)
NCT03433586 ·Status: UNKNOWN ·Phase: PHASE4
-
GM03 - Platelet RNA Signatures of Aspirin
NCT05278637 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Study of Platelet Function After Administration of Aspirin Versus Lysine Acetylsalicylate
NCT02243137 ·Status: COMPLETED ·Phase: PHASE1
-
Platelet Inhibition by Aspirin, Acetaminophen and NSAID
NCT00536068 ·Status: COMPLETED ·Phase: NA
-
The Impact of Aspirin Dose Modification on the Innate Immune Response - Will Lower Dose Aspirin Therapy Reduce the Response to Endotoxin
NCT03869268 ·Status: COMPLETED ·Phase: PHASE4
-
Aspirin Twice Daily in Diabetic Patients With Coronary Artery Disease
NCT01617031 ·Status: COMPLETED
-
Safety of Ticagrelor Monotherapy After Primary Percutaneous Coronary Intervention for ST-elevation Myocardial Infarction and the Effect on Intramyocardial Haemorrhage
NCT05986968 ·Status: RECRUITING ·Phase: NA
-
Study of Platelet Function After Administration of Aspirin Versus Lysine Acetylsalicylate in STEMI Patients
NCT02929888 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Platelet Hyperreactivity Project
NCT00976196 ·Status: COMPLETED
-
Thromboelastography As An Assessment Tool for Possible Clopidogrel and Aspirin Resistance
NCT00697021 ·Status: UNKNOWN ·Phase: PHASE3
-
Ticagrelor With Aspirin or Alone in High-Risk Patients After Coronary Intervention
NCT02270242 ·Status: COMPLETED ·Phase: PHASE4
-
Aspirin Response in High Risk Patients With Coronary Artery Disease
NCT01383304 ·Status: UNKNOWN
-
The Effect of Clopidogrel and Ticagrelor With and Without Acetylsalicylic Acid (ASA) on Hemostatic System Activation at the Site of Plug Formation in Vivo in Man
NCT02120092 ·Status: COMPLETED ·Phase: PHASE2